semaglutide manufacturing process novo nordisk What making weight-loss drugs means for the environment Company of the Year 2024:

Regular clinical monitoring becomes more important when managing multiple medications affecting digestion and nutrient uptake

Among the 14,606 patients without cirrhosis, GLP-1 RA use was associated with a lower risk of cirrhosis (hazard ratio [HR]: 0.86

From the payer perspective, the adjusted total cost per patient for the GLP-1RA group was higher than that for the insulin group by US$969, and from the healthcare sector perspective, the adjusted total cost per patient for the GLP-1RA group was lower than that for the insulin group by US$342

Abbreviations: RCT: randomized clinical trial, NAFLD: non-alcoholic fatty liver disease, NASH: non-alcoholic steatohepatitis, BBR: berberine, ALT: alanine aminotransferase, GGT: gamma-glutamyl transferase, WC: waist circumference, BMI: body mass index, HFC: hepatic fat content, Hb A1c: hemoglobin A1c, TG: triglycerides, LDL-c: low-density lipoprotein cholesterol, 2hPG: Two-hour post-load glucose, TC: total cholesterol, AST: aspartate aminotransferase, FPG: Fasting plasma glucose, HOMA-IR: Homeostatic Model Assessment for Insulin Resistance, FINS: fasting insulin, IR: insulin resistance, HDL: high-density lipoprotein

Adherence in trials is artificially high for instance, 92.8% of patients in a 2-year semaglutide trial completed the study (source)

Once people stop the medication, they tend to gain back two-thirds of the weight, if not more, he noted